Serdar Burmaoğlu

1.1k total citations
42 papers, 895 citations indexed

About

Serdar Burmaoğlu is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Serdar Burmaoğlu has authored 42 papers receiving a total of 895 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Organic Chemistry, 24 papers in Molecular Biology and 15 papers in Pharmacology. Recurrent topics in Serdar Burmaoğlu's work include Synthesis and biological activity (28 papers), Synthesis and Biological Evaluation (10 papers) and Computational Drug Discovery Methods (9 papers). Serdar Burmaoğlu is often cited by papers focused on Synthesis and biological activity (28 papers), Synthesis and Biological Evaluation (10 papers) and Computational Drug Discovery Methods (9 papers). Serdar Burmaoğlu collaborates with scholars based in Türkiye, Italy and Iraq. Serdar Burmaoğlu's co-authors include Öztekin Algül, İlhami Gülçın, Rüya Kaya, Mehmet Abdullah Alagöz, Nizami Duran, Ali Yılmaz, Aylin Döğen, Burak Kuzu, Parham Taslımı and Gözde Yalçın and has published in prestigious journals such as ACS Nano, Journal of Natural Products and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Serdar Burmaoğlu

40 papers receiving 883 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Serdar Burmaoğlu Türkiye 17 570 390 295 148 43 42 895
Adnan Çetin Türkiye 17 523 0.9× 374 1.0× 288 1.0× 170 1.1× 48 1.1× 47 855
Kanwal Pakistan 22 810 1.4× 318 0.8× 134 0.5× 184 1.2× 62 1.4× 48 1.2k
Abdhesh Kumar India 15 770 1.4× 242 0.6× 251 0.9× 73 0.5× 63 1.5× 25 1.1k
Ramit Singla India 11 610 1.1× 257 0.7× 139 0.5× 64 0.4× 57 1.3× 21 907
Rania B. Bakr Egypt 21 1.1k 2.0× 331 0.8× 193 0.7× 114 0.8× 88 2.0× 54 1.4k
Razieh Ghodsi Iran 22 872 1.5× 525 1.3× 266 0.9× 185 1.3× 95 2.2× 62 1.3k
Syed Shafi India 17 998 1.8× 482 1.2× 142 0.5× 90 0.6× 98 2.3× 65 1.4k
Afzal B. Shaik India 20 897 1.6× 355 0.9× 104 0.4× 211 1.4× 72 1.7× 60 1.3k
Prafulla B. Choudhari India 19 695 1.2× 315 0.8× 110 0.4× 202 1.4× 57 1.3× 106 1.2k
Mehreen Ghufran Pakistan 19 462 0.8× 231 0.6× 105 0.4× 119 0.8× 111 2.6× 39 857

Countries citing papers authored by Serdar Burmaoğlu

Since Specialization
Citations

This map shows the geographic impact of Serdar Burmaoğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serdar Burmaoğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serdar Burmaoğlu more than expected).

Fields of papers citing papers by Serdar Burmaoğlu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serdar Burmaoğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serdar Burmaoğlu. The network helps show where Serdar Burmaoğlu may publish in the future.

Co-authorship network of co-authors of Serdar Burmaoğlu

This figure shows the co-authorship network connecting the top 25 collaborators of Serdar Burmaoğlu. A scholar is included among the top collaborators of Serdar Burmaoğlu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serdar Burmaoğlu. Serdar Burmaoğlu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Özcan, Şeyda, et al.. (2025). Bischalcone derivatives with fluorine and methoxy functional groups: Synthesis, molecular docking, and biological evaluation as potential anticancer agents. Journal of Molecular Structure. 1329. 141468–141468. 1 indexed citations
2.
Çelik, Süleyman Utku, Banu İskender, Nicola Gambacorta, et al.. (2025). Synthesis and evaluation of sulfonamide-chalcone hybrid compounds as inhibitors of VEGFR1/VEGFR2-mediated angiogenesis. Bioorganic Chemistry. 164. 108903–108903.
3.
Algül, Öztekin, Burak Mete, Burçin Türkmenoğlu, et al.. (2024). Substituted bisbenzimidazole derivatives as multiple targeting agents to treat Alzheimer's disease, diabetes, and microbial infections. Journal of Molecular Structure. 1323. 140800–140800. 2 indexed citations
4.
Demir, Yeliz, et al.. (2024). Investigation of Some Metabolic Enzyme Inhibition Properties of Novel Chalcone‐Cu Complexes. ChemistrySelect. 9(27). 4 indexed citations
5.
Kuzu, Burak, Mehmet Abdullah Alagöz, Yeliz Demir, et al.. (2024). Structure-based inhibition of acetylcholinesterase and butyrylcholinesterase with 2-Aryl-6-carboxamide benzoxazole derivatives: synthesis, enzymatic assay, and in silico studies. Molecular Diversity. 29(1). 671–693. 24 indexed citations
6.
Alagöz, Mehmet Abdullah, et al.. (2023). Deep learning approach to the discovery of novel bisbenzazole derivatives for antimicrobial effect. Journal of Molecular Structure. 1295. 136668–136668. 9 indexed citations
8.
Yıldırım, Metin, Mehmet Abdullah Alagöz, Derya Yetkin, et al.. (2023). N-(benzazol-2-yl)-2-substituted phenylacetamide derivatives: Design, synthesis and biological evaluation against MCF7 breast cancer cell line. Journal of Molecular Structure. 1285. 135513–135513. 2 indexed citations
9.
Burmaoğlu, Serdar, et al.. (2023). Assessing the Antiangiogenic Effects of Chalcones and Their Derivatives. Polycyclic aromatic compounds. 44(1). 51–66. 3 indexed citations
10.
Sağlamtaş, Rüya, et al.. (2022). Exploring enzyme inhibition profiles of novel halogenated chalcone derivatives on some metabolic enzymes: Synthesis, characterization and molecular modeling studies. Computational Biology and Chemistry. 100. 107748–107748. 21 indexed citations
11.
Gambacorta, Nicola, et al.. (2021). Synthesis and biological evaluation of 3,5‐diaryl‐pyrazole derivatives as potential antiprostate cancer agents. Archiv der Pharmazie. 354(12). e2100225–e2100225. 7 indexed citations
12.
Burmaoğlu, Serdar, Gözde Yalçın, Ceylan Hepokur, et al.. (2021). Design, synthesis and biological evaluation of novel bischalcone derivatives as potential anticancer agents. Bioorganic Chemistry. 111. 104882–104882. 16 indexed citations
13.
Alagöz, Mehmet Abdullah, et al.. (2020). Bisbenzoxazole Derivatives: Design, Synthesis,in VitroAntimicrobial, Antiproliferative Activity, and Molecular Docking Studies. Polycyclic aromatic compounds. 42(6). 3103–3123. 9 indexed citations
14.
Burmaoğlu, Serdar, et al.. (2020). Synthesis of novel organohalogen chalcone derivatives and screening of their molecular docking study and some enzymes inhibition effects. Journal of Molecular Structure. 1208. 127868–127868. 47 indexed citations
15.
Burmaoğlu, Serdar, et al.. (2019). Synthesis of novel tris-chalcones and determination of their inhibition profiles against some metabolic enzymes. Archives of Physiology and Biochemistry. 127(2). 153–161. 41 indexed citations
17.
Burmaoğlu, Serdar, Şeyda Özcan, Sevgi Balcıoğlu, et al.. (2019). Synthesis, biological evaluation and molecular docking studies of bis-chalcone derivatives as xanthine oxidase inhibitors and anticancer agents. Bioorganic Chemistry. 91. 103149–103149. 59 indexed citations
19.
Burmaoğlu, Serdar, et al.. (2016). Synthesis and anti-proliferative activity of fluoro-substituted chalcones. Bioorganic & Medicinal Chemistry Letters. 26(13). 3172–3176. 52 indexed citations
20.
Burmaoğlu, Serdar, et al.. (2016). Synthesis of two phloroglucinol derivatives with cinnamyl moieties as inhibitors of the carbonic anhydrase isozymes I and II: anin vitrostudy. Journal of Enzyme Inhibition and Medicinal Chemistry. 31(sup2). 208–212. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026